Literature DB >> 27177742

Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.

Gustavo F Westin1, Ajoy L Dias1, Ronald S Go2.   

Abstract

Secondary analysis of large datasets has become a useful alternative to address research questions outside the reach of clinical trials. It is increasingly utilized in hematology and oncology. In this review, we provided an overview of some examples of commonly used large datasets in the USA and described common research themes that can be pursued using such a methodology. We selected a sample of 14 articles on adult hematologic malignancies published in 2015 and highlighted their contributions as well as limitations.

Entities:  

Keywords:  Acute myeloid leukemia; Amyloidosis; Diffuse large B cell lymphoma; Hematopoietic stem cell transplantation; Hodgkin lymphoma; Multiple myeloma

Mesh：

Year:  2016        PMID： 27177742     DOI： 10.1007/s11899-016-0331-4

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN： 1558-8211            Impact factor:   3.952


  54 in total

1.  An introduction To instrumental variables for epidemiologists

Authors: 
Journal:  Int J Epidemiol       Date:  2000-12       Impact factor: 7.196

2.  Commentary: chronic lymphocytic leukemia--the price of progress.

Authors:  Tait D Shanafelt; Heidi Gunderson; Timothy G Call
Journal:  Oncologist       Date:  2010-05-12

3.  Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience.

Authors:  Vaishali Sanchorawala; Fangui Sun; Karen Quillen; J Mark Sloan; John L Berk; David C Seldin
Journal:  Blood       Date:  2015-10-06       Impact factor: 22.113

4.  Association Between the Affordable Care Act Dependent Coverage Expansion and Cervical Cancer Stage and Treatment in Young Women.

Authors:  Anthony S Robbins; Xuesong Han; Elizabeth M Ward; Edgar P Simard; Zhiyuan Zheng; Ahmedin Jemal
Journal:  JAMA       Date:  2015-11-24       Impact factor: 56.272

5.  Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis.

Authors:  Shaji Kumar; Mei-Jie Zhang; Peigang Li; Angela Dispenzieri; Gustavo A Milone; Sagar Lonial; Amrita Krishnan; Angelo Maiolino; Baldeep Wirk; Brendan Weiss; César O Freytes; Dan T Vogl; David H Vesole; Hillard M Lazarus; Kenneth R Meehan; Mehdi Hamadani; Michael Lill; Natalie S Callander; Navneet S Majhail; Peter H Wiernik; Rajneesh Nath; Rammurti T Kamble; Ravi Vij; Robert A Kyle; Robert Peter Gale; Parameswaran N Hari
Journal:  Blood       Date:  2011-06-20       Impact factor: 22.113

6.  Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer.

Authors:  Nikki M Carroll; Thomas Delate; Alex Menter; Mark C Hornbrook; Lawrence Kushi; Erin J Aiello Bowles; Elizabeth T Loggers; Debra P Ritzwoller
Journal:  J Oncol Pract       Date:  2015-06-09       Impact factor: 3.840

7.  Improved long-term survival in multiple myeloma up to the age of 80 years.

Authors:  S Y Kristinsson; W F Anderson; O Landgren
Journal:  Leukemia       Date:  2014-01-14       Impact factor: 11.528

Review 8.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

9.  Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

Authors:  P Feugier; A Van Hoof; C Sebban; P Solal-Celigny; R Bouabdallah; C Fermé; B Christian; E Lepage; H Tilly; F Morschhauser; P Gaulard; G Salles; A Bosly; C Gisselbrecht; F Reyes; B Coiffier
Journal:  J Clin Oncol       Date:  2005-05-02       Impact factor: 44.544

10.  Black patients more likely than whites to undergo surgery at low-quality hospitals in segregated regions.

Authors:  Justin Dimick; Joel Ruhter; Mary Vaughan Sarrazin; John D Birkmeyer
Journal:  Health Aff (Millwood)       Date:  2013-06       Impact factor: 6.301
View more
  1 in total

1.  Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study.

Authors:  C Rioufol; F Ranchon; V Leclerc; L Karlin; C Herledan; L Marchal; A Baudouin; A Gouraud; A G Caffin; V Larbre; A Lazareth; E Bachy; G Salles; H Ghesquières
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-18       Impact factor: 4.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.